Barriers to Chimeric Antigen Receptor T-Cell Therapy

This cohort study examines barriers to access of CAR T-cell therapy among patients with hematologic cancer referred for this treatment.

Authors

Saad Z. Usmani (ORCID: https://orcid.org/0000-0002-5484-8731)
Kuo‐Kai Chin (ORCID: https://orcid.org/0000-0003-4504-398X)
Gunjan L. Shah (ORCID: https://orcid.org/0000-0002-9977-0456)
Briana Cadzin
Moneeza Walji
Roni Shouval (ORCID: https://orcid.org/0000-0001-9827-8032)
Mark Blaine Geyer (ORCID: https://orcid.org/0000-0001-5248-9117)
Chris Famulare
Paul W. Davis (ORCID: https://orcid.org/0000-0003-4637-3198)
Chelsea Brooklyn
Sean M. Devlin (ORCID: https://orcid.org/0000-0002-6801-720X)
Michael Scordo (ORCID: https://orcid.org/0000-0002-9484-0240)
Todd Goldstein (ORCID: https://orcid.org/0000-0001-8513-0581)
Caven S. Mcloughlin (ORCID: https://orcid.org/0000-0001-5482-5567)
Maria Lia Palomba (ORCID: https://orcid.org/0000-0001-5099-9156)
Elizabeth Cathcart (ORCID: https://orcid.org/0000-0002-3081-1635)
Alexander P. Boardman (ORCID: https://orcid.org/0000-0001-7169-9275)
Sham Mailankody (ORCID: https://orcid.org/0000-0002-2815-9561)
Eytan M. Stein (ORCID: https://orcid.org/0000-0001-8992-9390)
Sergio A. Giralt (ORCID: https://orcid.org/0000-0003-1944-5053)
Leora S. Boussi (ORCID: https://orcid.org/0000-0001-7018-2071)
David Nemirovsky (ORCID: https://orcid.org/0009-0007-6971-1408)
Gilles Salles (ORCID: https://orcid.org/0000-0002-9541-8666)
Meira Yisraeli Salman (ORCID: https://orcid.org/0000-0002-8504-2773)
Yannis K. Valtis (ORCID: https://orcid.org/0000-0001-8927-8006)
Jae H. Park (ORCID: https://orcid.org/0000-0002-2903-5130)
Miguel-Angel Perales